Pluristem Therapeutics Inc (PSTI.OQ)

PSTI.OQ on NASDAQ Stock Exchange Capital Market

2.95USD
11 Jul 2014
Price Change (% chg)

$0.02 (+0.68%)
Prev Close
$2.93
Open
$2.99
Day's High
$2.99
Day's Low
$2.95
Volume
6,668
Avg. Vol
30,765
52-wk High
$4.63
52-wk Low
$2.85

PSTI.OQ

Chart for PSTI.OQ

About

Pluristem Therapeutics Inc. (Pluristem) is a bio-therapeutics company engaged in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived... (more)

Overall

Beta: 1.13
Market Cap (Mil.): $198.98
Shares Outstanding (Mil.): 67.91
Dividend: --
Yield (%): --

Financials

  PSTI.OQ Industry Sector
P/E (TTM): -- 99.11 35.83
EPS (TTM): -0.45 -- --
ROI: -39.75 -0.58 18.29
ROE: -42.66 -1.43 19.18
Search Stocks

BRIEF-Pluristem Therapeutics up 7.2 percent premarket

NEW YORK, Jan 21 - Pluristem Therapeutics Inc : * Up 7.2 percent to $4.75 in premarket after muscle injury treatment trial results

21 Jan 2014

Pluristem stem cell trial to treat muscle injury meets main goal

TEL AVIV - Pluristem Therapeutics Inc said results from its early/mid-stage clinical trial indicated its placenta-derived stem cells for the treatment of muscle injury were safe and provided evidence the cells might be effective in treating orthopedic injuries.

21 Jan 2014

Pluristem stem cell trial to treat muscle injury meets main goal

TEL AVIV, Jan 21 - Pluristem Therapeutics Inc said results from its early/mid-stage clinical trial indicated its placenta-derived stem cells for the treatment of muscle injury were safe and provided evidence the cells might be effective in treating orthopedic injuries.

21 Jan 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks